 Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores
Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores Equitas Small Finance Bank Ltd posts PAT of Rs. 24.13 crores in Q2 FY2025-26
Equitas Small Finance Bank Ltd posts PAT of Rs. 24.13 crores in Q2 FY2025-26 Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26
Saint-Gobain Sekurit India Ltd posts Rs. 10.76 crores PAT in Q2FY26 Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores
Strides Pharma Science Ltd consolidated Q2FY26 net profit climbs to Rs. 127.53 crores 
              The Board of Directors of Venus Remedies Ltd at its meeting held on June 24, 2016, has considered that in the light of the delay in some pending permissions, the Board has decided to withdraw the proposal of Preferential Allotment of 9,00,000 equity shares of Rs. 10/- each approved at AGM held on August 25, 2015 with liberty to consider a fresh proposal of allotment of shares at an appropriate stage by placing the same before the general meeting.
Shares of VENUS REMEDIES LTD. was last trading in BSE at Rs.76.05 as compared to the previous close of Rs. 79.35. The total number of shares traded during the day was 9776 in over 200 trades.
The stock hit an intraday high of Rs. 77.7 and intraday low of 72.8. The net turnover during the day was Rs. 736392.